Bacterial Vaginitis. Other bacterial agents as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: Patients with bacterial vaginitis treated with vaginal vitamin C 250 mg daily for seven days and clinical and laboratory symptoms will be assessed before and after
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women with bacterial vaginitis base on clinical symptoms and laboratory findings
Exclusion criteria
Exclusion criteria: Patients with immunodeficiency or HIV positive Women with genital and urinary tract infections Menstruation at the time of attendance Pregnant Vitamin C sesitivity Women who do not allow pelvic examination Taking any vaginal drugs, antibiotics, and immune-suppressing drugs and exogenous hormones, including oral contraceptives, during the 2 weeks prior to the study. Having intercourse or using vaginal douche within the last 24 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bacterial Vaginitis. Timepoint: Clinical signs and bacterial composition of direct smear will be assessed at baseline (before intervention) and 7 days after administration of Vitamin C. Method of measurement: Questionnaire containing demographic information and clinical symptoms.;Improve vaginal bacterial composition. Timepoint: Bacterial composition of direct smear at baseline (before intervention) and 7 days after intervention. Method of measurement: Direct smear assessment before treatment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Zahra Vahedipoor
Kashan University of Medical Sciences
Outcome results
None listed